Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) Sees Large Drop in Short Interest

Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) was the recipient of a significant decline in short interest in the month of July. As of July 15th, there was short interest totaling 25,239 shares, a decline of 50.1% from the June 30th total of 50,577 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Kissei Pharmaceutical Price Performance

Kissei Pharmaceutical stock remained flat at $25.77 during midday trading on Wednesday. The business’s fifty day moving average is $25.77 and its two-hundred day moving average is $26.16. Kissei Pharmaceutical has a 1 year low of $23.23 and a 1 year high of $31.90.

About Kissei Pharmaceutical

Kissei Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company that specializes in the research, development and manufacture of prescription drugs across a range of therapeutic areas. Founded in 1946 and incorporated in 1950, Kissei has built a reputation for its work in urology, nephrology, endocrinology, respiratory medicine and oncology. Through its dedicated in-house research centers, the company advances novel small molecules and biologic candidates from early discovery through clinical development.

The company’s product portfolio includes treatments for benign prostatic hyperplasia, chronic kidney disease, type 2 diabetes and various forms of cancer.